ReviewDie Ophthalmologie2026
[Multilevel revision after complicated cataract surgery. Video article].
Review in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
indicationsThe aim of the multilevel revision is a single-stage, ideally definitive surgical treatment of corneal-endothelial-epithelial decompensation and bullous keratopathy caused by an anterior chamber iris claw intraocular lens (IOL) by means of IOL explantation, complete pars plana vitrectomy, secondary IOL implantation and simultaneous Descemet membrane endothelial keratoplasty (DMEK). The prerequisite for surgery is the absence of pre-Descemet corneal scars. SURGICAL TECHNIQUE: For complete mobilization of the dislocated anterior chamber IOL the haptics are severed and the lens is removed through a 6 mm wide superior sclerocorneal tunnel. Complete anterior and posterior 25-gauge vitrectomy is performed including removal of the active posterior vitreous detachment. After manual iris tissue stretching, a retroiridal iris claw IOL is implanted. In the end, DMEK with a donor graft size of 7.5 mm is performed via temporal access for treatment of the corneal decompensation.
conclusionIn patients with corneal-endothelial-epithelial decompensation and bullous keratopathy due to a dislocated anterior chamber IOL, IOL explantation with complete vitrectomy, secondary implantation of a retroiridal, iris-fixated IOL and combined DMEK is an effective, single-stage surgical treatment. VIDEO ONLINE: The online version of this article contains a video.
Indexed as
Identifiers
41649509What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.